BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26218418)

  • 1. Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis.
    Schugar RC; Brown JM
    Curr Opin Lipidol; 2015 Oct; 26(5):426-31. PubMed ID: 26218418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethylamine
    Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
    Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
    J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.
    Petriello MC; Hoffman JB; Sunkara M; Wahlang B; Perkins JT; Morris AJ; Hennig B
    J Nutr Biochem; 2016 Jul; 33():145-53. PubMed ID: 27155921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.
    Warrier M; Shih DM; Burrows AC; Ferguson D; Gromovsky AD; Brown AL; Marshall S; McDaniel A; Schugar RC; Wang Z; Sacks J; Rong X; Vallim TA; Chou J; Ivanova PT; Myers DS; Brown HA; Lee RG; Crooke RM; Graham MJ; Liu X; Parini P; Tontonoz P; Lusis AJ; Hazen SL; Temel RE; Brown JM
    Cell Rep; 2015 Jan; 10(3):326-338. PubMed ID: 25600868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.
    Iglesias-Carres L; Chadwick-Corbin SA; Sweet MG; Neilson AP
    J Nutr Biochem; 2023 Oct; 120():109428. PubMed ID: 37549832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief Report.
    Shih DM; Zhu W; Schugar RC; Meng Y; Jia X; Miikeda A; Wang Z; Zieger M; Lee R; Graham M; Allayee H; Cantor RM; Mueller C; Brown JM; Hazen SL; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1045-1054. PubMed ID: 31070450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
    Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.
    Shih DM; Wang Z; Lee R; Meng Y; Che N; Charugundla S; Qi H; Wu J; Pan C; Brown JM; Vallim T; Bennett BJ; Graham M; Hazen SL; Lusis AJ
    J Lipid Res; 2015 Jan; 56(1):22-37. PubMed ID: 25378658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.
    Collins HL; Drazul-Schrader D; Sulpizio AC; Koster PD; Williamson Y; Adelman SJ; Owen K; Sanli T; Bellamine A
    Atherosclerosis; 2016 Jan; 244():29-37. PubMed ID: 26584136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of trimethylamine-N-oxide in the pathogenesis of atherosclerosis].
    He H; Lian X; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):986-990. PubMed ID: 28872093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.
    Luo T; Guo Z; Liu D; Guo Z; Wu Q; Li Q; Lin R; Chen P; Ou C; Chen M
    Gut Microbes; 2022; 14(1):2077602. PubMed ID: 35613310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
    Fennema D; Phillips IR; Shephard EA
    Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis.
    Wilson A; McLean C; Kim RB
    Curr Opin Lipidol; 2016 Apr; 27(2):148-54. PubMed ID: 26959704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.
    Schugar RC; Shih DM; Warrier M; Helsley RN; Burrows A; Ferguson D; Brown AL; Gromovsky AD; Heine M; Chatterjee A; Li L; Li XS; Wang Z; Willard B; Meng Y; Kim H; Che N; Pan C; Lee RG; Crooke RM; Graham MJ; Morton RE; Langefeld CD; Das SK; Rudel LL; Zein N; McCullough AJ; Dasarathy S; Tang WHW; Erokwu BO; Flask CA; Laakso M; Civelek M; Naga Prasad SV; Heeren J; Lusis AJ; Hazen SL; Brown JM
    Cell Rep; 2017 Jun; 19(12):2451-2461. PubMed ID: 28636934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.
    Bennett BJ; de Aguiar Vallim TQ; Wang Z; Shih DM; Meng Y; Gregory J; Allayee H; Lee R; Graham M; Crooke R; Edwards PA; Hazen SL; Lusis AJ
    Cell Metab; 2013 Jan; 17(1):49-60. PubMed ID: 23312283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaorganismal nutrient metabolism as a basis of cardiovascular disease.
    Brown JM; Hazen SL
    Curr Opin Lipidol; 2014 Feb; 25(1):48-53. PubMed ID: 24362355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine
    Veeravalli S; Karu K; Scott F; Fennema D; Phillips IR; Shephard EA
    Drug Metab Dispos; 2018 Jan; 46(1):20-25. PubMed ID: 29070510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hif-1α expression targets the TMA/Fmo3/TMAO axis to participate in gallbladder cholesterol stone formation in individuals living in plateau regions.
    Luo M; Chen P; Tian Y; Rigzin N; Sonam J; Shang F; Tai C; Li T; Sang H
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167188. PubMed ID: 38657913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.